TY - JOUR
T1 - Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas
T2 - Interim analysis of the prospective PANCY survey
AU - Pezzilli, Raffaele
AU - Buscarini, Elisabetta
AU - Pollini, Tommaso
AU - Bonamini, Deborah
AU - Marchegiani, Giovanni
AU - Crippa, Stefano
AU - Belfiori, Giulio
AU - Sperti, Cosimo
AU - Moletta, Lucia
AU - Pozza, Gioia
AU - De Nucci, Germana
AU - Manes, Giampiero
AU - Mandelli, Enzo D
AU - Casadei, Riccardo
AU - Ricci, Claudio
AU - Alicante, Saverio
AU - Vattiato, Claudia
AU - Carrara, Silvia
AU - Di Leo, Milena
AU - Fabbri, Carlo
AU - Giovanelli, Silvia
AU - Barresi, Luca
AU - Tacelli, Matteo
AU - Mirante, Vincenzo G
AU - Conigliaro, Rita
AU - Antonini, Filippo
AU - Macarri, Giampiero
AU - Frulloni, Luca
AU - De Marchi, Giulia
AU - Sassatelli, Romano
AU - Cecinato, Paolo
AU - Del Vecchio Blanco, Giovanna
AU - Galli, Andrea
AU - Pezzullo, Angelo
AU - Fantin, Alberto
AU - Graffeo, Massimo
AU - Frego, Mauro
AU - Stillittano, Domenico
AU - Monica, Fabio
AU - Germanà, Bastianello
AU - Capurso, Gabriele
AU - Quartini, Mariano
AU - Veneroni, Luigi
AU - Cannizzaro, Renato
AU - Falconi, Massimo
N1 - Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
PY - 2020/5
Y1 - 2020/5
N2 - INTRODUCTION: A prospective survey to evaluate the diagnostic workup of cystic pancreatic neoplasms (CPNs) according to the Italian guidelines.METHODS: An online data sheet was built.RESULTS: Fifteen of the 1385 patients (1.1%) had non cystic neoplastic lesions. Forty percent (518/1295) had at least one 1st degree relative affected by a solid tumor of the digestive and extra-digestive organs. Symptoms/signs associated with the cystic lesion were present in 24.5% of the patients. The cysts were localized in the head of the pancreas in 38.5% of patients. Of the 2370 examinations (1.7 examinations per patient) which were carried out for the diagnosis, magnetic resonance imaging was performed as a single test in 48.4% of patients and in combination with endoscopic ultrasound in 27% of the cases. Of the 1370 patients having CPNs, 89.9% had an intraductal papillary mucinous neoplasm (IPMN) (70.1% a branch duct IPMN, 6.2% a mixed type IPMN and 4.6% a main duct IPMN), 12.7% had a serous cystadenoma, 2.8% a mucinous cystadenoma, 1.5% a non-functioning cystic neuroendocrine neoplasm, 0.7% a solid-pseudopapillary cystic neoplasm, 0.3% a cystic adenocarcinoma, and 1.2% an undetermined cystic neoplasm. Seventy-eight (5.7%) patients were operated upon after the initial work-up.CONCLUSIONS: This prospective study offers a reliable real-life picture of the diagnostic work-up CPN.
AB - INTRODUCTION: A prospective survey to evaluate the diagnostic workup of cystic pancreatic neoplasms (CPNs) according to the Italian guidelines.METHODS: An online data sheet was built.RESULTS: Fifteen of the 1385 patients (1.1%) had non cystic neoplastic lesions. Forty percent (518/1295) had at least one 1st degree relative affected by a solid tumor of the digestive and extra-digestive organs. Symptoms/signs associated with the cystic lesion were present in 24.5% of the patients. The cysts were localized in the head of the pancreas in 38.5% of patients. Of the 2370 examinations (1.7 examinations per patient) which were carried out for the diagnosis, magnetic resonance imaging was performed as a single test in 48.4% of patients and in combination with endoscopic ultrasound in 27% of the cases. Of the 1370 patients having CPNs, 89.9% had an intraductal papillary mucinous neoplasm (IPMN) (70.1% a branch duct IPMN, 6.2% a mixed type IPMN and 4.6% a main duct IPMN), 12.7% had a serous cystadenoma, 2.8% a mucinous cystadenoma, 1.5% a non-functioning cystic neuroendocrine neoplasm, 0.7% a solid-pseudopapillary cystic neoplasm, 0.3% a cystic adenocarcinoma, and 1.2% an undetermined cystic neoplasm. Seventy-eight (5.7%) patients were operated upon after the initial work-up.CONCLUSIONS: This prospective study offers a reliable real-life picture of the diagnostic work-up CPN.
U2 - 10.1016/j.dld.2020.02.003
DO - 10.1016/j.dld.2020.02.003
M3 - Article
C2 - 32122771
VL - 52
SP - 547
EP - 554
JO - Dig. Liver Dis.
JF - Dig. Liver Dis.
SN - 1590-8658
IS - 5
ER -